Yong Wang
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 32
- Circular RNAs in diseases 14
- Advanced biosensing and bioanalysis techniques 13
-
- Nanoplatforms for cancer theranostics 39
- Co-authors
- Xintao Shuai (51 shared papers)Robert R. Rando (2 shared papers)Hong Xiao (15 shared papers)Du Cheng (9 shared papers)Yongcheng An (7 shared papers)Daohong Zhou (5 shared papers)Zecong Xiao (11 shared papers)Shisong Han (7 shared papers)
- Journals
- Blood (6 papers)Biomaterials Science (5 papers)RSC Advances (4 papers)Scientific Reports (4 papers)Journal of Materials Chemistry B (4 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Yong Wang
233 papers receiving 8.8k citations
Yong Wang's Hit Papers
Peers
Comparison fields: 5 of 154
- Cancer Research 1.5k
- Biomaterials 1.1k
- Immunology 1.4k
- Molecular Biology 3.6k
- Oncology 1.3k
Countries citing papers authored by Yong Wang
This map shows the geographic impact of Yong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong Wang more than expected).
Fields of papers citing papers by Yong Wang
This network shows the impact of papers produced by Yong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong Wang. The network helps show where Yong Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yong Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 243 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | FoxM1 Promotes β-Catenin Nuclear Localization and Controls Wnt Target-Gene Expression and Glioma Tumorigenesis Hit paper breakdown → | 2011 | 482 |
| 2 | 2005 | 333 | |
| 3 | Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study Hit paper breakdown → | 2021 | 263 |
| 4 | 2009 | 250 | |
| 5 | Plasma microRNAs as novel biomarkers for early detection of lung cancer. | 2011 | 225 |
| 6 | 2009 | 214 | |
| 7 | 2014 | 200 | |
| 8 | 1995 | 198 | |
| 9 | Nanodrug with dual-sensitivity to tumor microenvironment for immuno-sonodynamic anti-cancer therapy Hit paper breakdown → | 2021 | 190 |
| 10 | 2020 | 186 | |
| 11 | 2020 | 179 | |
| 12 | 2020 | 163 | |
| 13 | 2005 | 160 | |
| 14 | 2020 | 159 | |
| 15 | 2016 | 157 | |
| 16 | 2020 | 151 | |
| 17 | 1997 | 150 | |
| 18 | 2010 | 135 | |
| 19 | 2018 | 118 | |
| 20 | 2013 | 113 |
About Yong Wang
Yong Wang is a scholar working on Molecular Biology, Biomedical Engineering, Immunology, Oncology and Biomaterials, having authored 243 papers that have together received 9.0k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (39 papers), Nanoparticle-Based Drug Delivery (36 papers), RNA Interference and Gene Delivery (32 papers), MicroRNA in disease regulation (25 papers), Immunotherapy and Immune Responses (16 papers), Immune cells in cancer (15 papers), Circular RNAs in diseases (14 papers) and Advanced biosensing and bioanalysis techniques (13 papers). The work is most often cited by research in Cancer Research (1.5k citations), Biomaterials (1.1k citations), Immunology (1.4k citations), Molecular Biology (3.6k citations) and Oncology (1.3k citations). Yong Wang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Xintao Shuai, Robert R. Rando, Hong Xiao, Du Cheng, Yongcheng An, Daohong Zhou, Zecong Xiao, Shisong Han, Bo Li and Jingguo Li. Their work appears in journals such as Blood, Biomaterials Science, RSC Advances, Scientific Reports and Journal of Materials Chemistry B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.